Literature DB >> 22045305

Reconstitution of regulatory T cells after autologous transplantation in multiple myeloma.

Prasanth Ganeshan, Ritu Gupta, Mrinali Hakim, Lalit Kumar, Archana Bhaskar, Atul Sharma.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22045305     DOI： 10.1007/s12185-011-0958-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  Significantly reduced regulatory T cell population in patients with untreated multiple myeloma.

Authors:  Ritu Gupta; Prasanth Ganeshan; Mrinali Hakim; Rakesh Verma; Atul Sharma; Lalit Kumar
Journal:  Leuk Res       Date:  2010-12-10       Impact factor: 3.156

Review 2.  Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.

Authors:  T Guillaume; D B Rubinstein; M Symann
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

Review 3.  Regulating regulatory T cells.

Authors:  N T Le; N Chao
Journal:  Bone Marrow Transplant       Date:  2006-10-23       Impact factor: 5.483

4.  Reconstitution of naïve T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer.

Authors:  D K Mitra; H P Singh; M Singh; A Alwadi; V Kochupillai; V Raina; L Kumar; N K Mehra
Journal:  Transplantation       Date:  2002-04-27       Impact factor: 4.939

Review 5.  Regulatory T cells in cancer.

Authors:  Marc Beyer; Joachim L Schultze
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

6.  A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

Authors:  Kimberly Noonan; Luigi Marchionni; Judy Anderson; Drew Pardoll; G David Roodman; Ivan Borrello
Journal:  Blood       Date:  2010-07-27       Impact factor: 22.113

7.  CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

Authors:  Djordje Atanackovic; Yanran Cao; Tim Luetkens; Jens Panse; Christiane Faltz; Julia Arfsten; Katrin Bartels; Christine Wolschke; Thomas Eiermann; Axel R Zander; Boris Fehse; Carsten Bokemeyer; Nicolaus Kroger
Journal:  Haematologica       Date:  2008-02-20       Impact factor: 9.941

Review 8.  Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.

Authors:  J Kline; S Subbiah; H M Lazarus; K van Besien
Journal:  Bone Marrow Transplant       Date:  2007-11-19       Impact factor: 5.483

9.  Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Richard K Burt; Syamal K Datta
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

10.  CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.

Authors:  Sylvia Feyler; Marie von Lilienfeld-Toal; Sarah Jarmin; Lee Marles; Andy Rawstron; A J Ashcroft; Roger G Owen; Peter J Selby; Gordon Cook
Journal:  Br J Haematol       Date:  2008-12-26       Impact factor: 6.998
View more
  2 in total

1.  Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients.

Authors:  Egor V Batorov; Marina A Tikhonova; Natalia V Pronkina; Irina V Kryuchkova; Vera V Sergeevicheva; Svetlana A Sizikova; Galina Y Ushakova; Tatiana A Aristova; Dariya S Batorova; Elena V Menyaeva; Andrey V Gilevich; Ekaterina Y Shevela; Alexander A Ostanin; Elena R Chernykh
Journal:  Oncotarget       Date:  2018-06-05

2.  Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study.

Authors:  Benjamin A Derman; Yuanyuan Zha; Todd M Zimmerman; Rebecca Malloy; Andrzej Jakubowiak; Michael R Bishop; Justin Kline
Journal:  J Immunother Cancer       Date:  2020-01       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.